NCT00509834 - A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia | Biotech Hunter

Timeline

Start Date

July 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Candidaemia

Interventions

DRUG

hLF1-11

"The study treatment consists of IV administration of:~(A) hLF1-11 (0.5mg IV bolus daily for 14 days) + fluconazole (up to 1g IV four times daily; 14 days): Group #1, n=10; OR (B) Fluconazole (up to 1g IV four times daily; 14 days) + matching placebo for hLF1-11: Group #2, n=10"

DRUG

hLF1-11

0.5mg hLF1-11 iv per day for 14 consecutive days

DRUG

Placebo

Trial Locations (1)

6500 HB

UMC St. Radboud, Nijmegen